Chester A. Mathis

58.9k total citations · 18 hit papers
356 papers, 32.2k citations indexed

About

Chester A. Mathis is a scholar working on Physiology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chester A. Mathis has authored 356 papers receiving a total of 32.2k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Physiology, 135 papers in Psychiatry and Mental health and 99 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chester A. Mathis's work include Alzheimer's disease research and treatments (147 papers), Dementia and Cognitive Impairment Research (129 papers) and Medical Imaging Techniques and Applications (62 papers). Chester A. Mathis is often cited by papers focused on Alzheimer's disease research and treatments (147 papers), Dementia and Cognitive Impairment Research (129 papers) and Medical Imaging Techniques and Applications (62 papers). Chester A. Mathis collaborates with scholars based in United States, United Kingdom and Germany. Chester A. Mathis's co-authors include William E. Klunk, Julie C. Price, Steven T. DeKosky, Brian J. Lopresti, Daniel P. Holt, Manik L. Debnath, Mark A. Mintun, William J. Jagust, Guo-Feng Huang and John C. Morris and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Chester A. Mathis

350 papers receiving 31.5k citations

Hit Papers

Molecular, Structural, an... 1999 2026 2008 2017 2005 2005 2006 2003 2007 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
    2005 1.6k citations William E. Klunk, Chester A. Mathis et al. profile →
  2. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
    2005 960 citations Robert H. Mach, William E. Klunk et al. profile →
  3. [ 11 C]PIB in a nondemented population
    2006 833 citations Robert H. Mach, William E. Klunk et al. Neurology profile →
  4. Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
    2003 828 citations Chester A. Mathis, Daniel P. Holt et al. Journal of Medicinal Chemistry profile →
  5. Imaging β-amyloid burden in aging and dementia
    2007 813 citations William E. Klunk, Chester A. Mathis et al. Neurology profile →
  6. Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
    2008 799 citations Howard Aizenstein, Julie C. Price et al. profile →
  7. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment
    2008 758 citations William E. Klunk, Chester A. Mathis et al. profile →
  8. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
    2014 690 citations William E. Klunk, Julie C. Price et al. profile →
  9. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
    2008 681 citations Miloš D. Ikonomović, William E. Klunk et al. profile →
  10. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
    2011 638 citations Victor L. Villemagne, Pierrick Bourgeat et al. profile →
  11. Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
    2009 618 citations Eric M. Reiman, Kewei Chen et al. Proceedings of the National Academy of Sciences profile →
  12.  -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
    2007 616 citations Chester A. Mathis, William E. Klunk et al. profile →
  13. Episodic memory loss is related to hippocampal-mediated  -amyloid deposition in elderly subjects
    2008 546 citations Chester A. Mathis et al. profile →
  14. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
    2005 544 citations Julie C. Price, William E. Klunk et al. profile →
  15. 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
    2010 536 citations William E. Klunk, Chester A. Mathis et al. profile →
  16. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
    2001 522 citations Wayne C. Drevets, Julie C. Price et al. profile →
  17. Pet imaging of serotonin 1A receptor binding in depression
    1999 503 citations Wayne C. Drevets, Julie C. Price et al. profile →
  18. Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue
    2015 450 citations William E. Klunk, Chester A. Mathis et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Chester A. Mathis 17.4k 13.9k 7.6k 6.2k 5.2k 356 32.2k
Harald Hampel 17.8k 1.0× 13.9k 1.0× 7.8k 1.0× 4.5k 0.7× 7.6k 1.5× 496 35.3k
Hilkka Soininen 16.8k 1.0× 16.1k 1.2× 7.7k 1.0× 3.1k 0.5× 6.5k 1.3× 680 40.6k
Victor L. Villemagne 14.4k 0.8× 11.4k 0.8× 5.4k 0.7× 3.9k 0.6× 4.7k 0.9× 538 26.2k
Eric M. Reiman 15.1k 0.9× 11.9k 0.9× 10.5k 1.4× 4.5k 0.7× 5.7k 1.1× 469 34.5k
William E. Klunk 24.9k 1.4× 22.3k 1.6× 10.1k 1.3× 6.9k 1.1× 7.2k 1.4× 342 44.3k
Mony J. de Leon 13.6k 0.8× 11.8k 0.8× 6.1k 0.8× 3.7k 0.6× 4.6k 0.9× 304 31.0k
Reisa A. Sperling 18.6k 1.1× 19.6k 1.4× 15.9k 2.1× 5.7k 0.9× 4.3k 0.8× 534 41.5k
Leslie M. Shaw 17.1k 1.0× 16.2k 1.2× 6.1k 0.8× 3.9k 0.6× 6.0k 1.2× 363 34.0k
Bruno Dubois 15.0k 0.9× 18.9k 1.4× 12.7k 1.7× 3.4k 0.6× 4.4k 0.9× 419 39.4k
Richard Mayeux 21.3k 1.2× 19.9k 1.4× 7.4k 1.0× 2.7k 0.4× 8.3k 1.6× 518 52.7k

Countries citing papers authored by Chester A. Mathis

Since Specialization
Citations

This map shows the geographic impact of Chester A. Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester A. Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester A. Mathis more than expected).

Fields of papers citing papers by Chester A. Mathis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chester A. Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester A. Mathis. The network helps show where Chester A. Mathis may publish in the future.

Co-authorship network of co-authors of Chester A. Mathis

This figure shows the co-authorship network connecting the top 25 collaborators of Chester A. Mathis. A scholar is included among the top collaborators of Chester A. Mathis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chester A. Mathis. Chester A. Mathis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tong, Junchao, N. Scott Mason, Daniel Sohn, et al.. (2024). Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies. Nature Communications. 15(1). 5109–5109. 19 indexed citations
3.
Gogola, Alexandra, Brian J. Lopresti, Dana Tudorascu, et al.. (2023). Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies. Journal of Nuclear Medicine. 64(11). 1798–1805. 8 indexed citations
4.
Graham, Thomas J. A., Junchao Tong, Jeffrey S. Stehouwer, et al.. (2023). In Silico Discovery and Subsequent Characterization of Potent 4R-Tauopathy Positron Emission Tomography Radiotracers. Journal of Medicinal Chemistry. 66(15). 10628–10638. 13 indexed citations
5.
Knight, Ashley C., Daniel Sohn, Junchao Tong, et al.. (2021). Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies. ACS Chemical Neuroscience. 12(4). 596–602. 36 indexed citations
6.
Zammit, Matthew, Davneet Minhas, Paul A. Ellison, et al.. (2020). Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline. Alzheimer s & Dementia Translational Research & Clinical Interventions. 6(1). e12096–e12096. 23 indexed citations
7.
Tudorascu, Dana, Stewart Anderson, Davneet Minhas, et al.. (2018). Comparison of longitudinal Aβ in nondemented elderly and Down syndrome. Neurobiology of Aging. 73. 171–176. 12 indexed citations
8.
Yan, Qi, Kwangsik Nho, Jorge L. Del‐Aguila, et al.. (2018). Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. Digital Commons@Becker (Washington University School of Medicine). 1 indexed citations
9.
Resnick, Susan M., Jitka Sojkova, Zhou Yu, et al.. (2010). Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [ 11 C]PiB. Neurology. 74(10). 807–815. 212 indexed citations
10.
Reiman, Eric M., Kewei Chen, Xiaofen Liu, et al.. (2009). Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proceedings of the National Academy of Sciences. 106(16). 6820–6825. 618 indexed citations breakdown →
11.
Butters, Meryl A., William E. Klunk, Chester A. Mathis, et al.. (2008). Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B. Alzheimer Disease & Associated Disorders. 22(3). 261–268. 107 indexed citations
12.
Sojkova, Jitka, Lori L. Beason‐Held, Yun Zhou, et al.. (2008). Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?. Journal of Nuclear Medicine. 49(9). 1465–1471. 59 indexed citations
13.
Ikonomović, Miloš D., Eric E. Abrahamson, Barbara A. Isanski, et al.. (2006). X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease. Methods in enzymology on CD-ROM/Methods in enzymology. 123–144. 45 indexed citations
14.
Brendza, Robert P., Brian J. Bacskai, John R. Cirrito, et al.. (2005). Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. Journal of Clinical Investigation. 115(2). 428–433. 23 indexed citations
15.
Venneti, Sriram, Brian J. Lopresti, Guoji Wang, et al.. (2004). PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS. Journal of Clinical Investigation. 113(7). 981–989. 42 indexed citations
16.
Meltzer, Carolyn C., Wayne C. Drevets, Julie C. Price, et al.. (2000). Gender-specific aging reductions in [11C-carbonyl] WAY100635 binding: Not an effect of atrophy. NeuroImage. 11. 1 indexed citations
17.
Lawler, Cindy P., John H. Gilmore, Val J. Watts, et al.. (1995). Interhemispheric modulation of dopamine receptor interactions in unilateral 6‐OHDA rodent model. Synapse. 21(4). 299–311. 22 indexed citations
18.
Mathis, Chester A., et al.. (1991). Synthesis of aryl-substituted 5-[18F]fluoroalkylbenzamides: High affinity ligands for dopamine D-2 studies. Journal of Labelled Compounds and Radiopharmaceuticals. 30. 357–359. 2 indexed citations
19.
Mathis, Chester A., et al.. (1991). Synthesis and evaluation of (S)-5-[125I]iodo-2,3-methylenedioxybenzamide. Journal of Labelled Compounds and Radiopharmaceuticals. 30. 1 indexed citations
20.
Mathis, Chester A., et al.. (1977). Unification of idempotent functions. International Joint Conference on Artificial Intelligence. 528–528. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harald Hampel Breakdown of academic impact, for papers by Hilkka Soininen Breakdown of academic impact, for papers by Victor L. Villemagne Breakdown of academic impact, for papers by Eric M. Reiman Breakdown of academic impact, for papers by William E. Klunk Breakdown of academic impact, for papers by Mony J. de Leon Breakdown of academic impact, for papers by Reisa A. Sperling Breakdown of academic impact, for papers by Leslie M. Shaw Breakdown of academic impact, for papers by Bruno Dubois Breakdown of academic impact, for papers by Richard Mayeux
Rankless by CCL
2026